CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 65 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $210,000 | +56.7% | 243,711 | +0.1% | 0.11% | +7.1% |
| Q2 2022 | $134,000 | -34.0% | 243,539 | +33.1% | 0.10% | -11.6% |
| Q1 2022 | $203,000 | +17.3% | 182,930 | +82.1% | 0.11% | -15.2% |
| Q4 2021 | $173,000 | -19.2% | 100,480 | +43.9% | 0.13% | -21.9% |
| Q3 2021 | $214,000 | -31.6% | 69,818 | -13.1% | 0.17% | -25.2% |
| Q2 2021 | $313,000 | – | 80,336 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |